tarsus-logo-stacked-color-532x626.png
Tarsus Announces Transition Plans for Board of Directors
October 11, 2022 08:30 ET | Tarsus Pharmaceuticals, Inc
Co-founder and Chairman Michael Ackermann plans to transition off Board of Directors Wendy Yarno will become Lead Independent Director and CEO Bobak Azamian will become Chairman upon Dr. Ackermann’s...
tarsus-logo-stacked-color-532x626.png
Tarsus Appoints Scott Morrison as Board Member and Audit Committee Chair
October 06, 2022 08:30 ET | Tarsus Pharmaceuticals, Inc
Mr. Morrison brings over 40 years of financial and operational expertise in life sciences IRVINE, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose...
Look at the Lids Website
Tarsus Launches “Look at the Lids” Campaign to Encourage Eye Care Professionals to Identify and Diagnose Demodex Blepharitis
September 29, 2022 08:30 ET | Tarsus Pharmaceuticals, Inc
Demodex blepharitis is a highly prevalent, yet often missed or misdiagnosed lid margin disease that impacts approximately 25 million eye care patients in the U.S. IRVINE, Calif., Sept. 29, 2022 ...
Intraocular Lens Market
Insights on the Intraocular Lens Global Market to 2031 - Rising Adoption of Premium Lens is Driving Growth
September 28, 2022 05:03 ET | Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Intraocular Lens Market By Type, By Material, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ...
tarsus-logo-stacked-color-532x626.png
Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings
September 27, 2022 12:00 ET | Tarsus Pharmaceuticals, Inc
Positive data to be presented at WCC VIII and AAO 2022 conferences in Chicago Tarsus recently submitted NDA to the FDA for TP-03 IRVINE, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Tarsus...
22157.jpg
Global Glaucoma Treatment Market Report 2022: Continuous Drug Innovations Presents Opportunities
September 20, 2022 05:18 ET | Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Glaucoma treatment Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global glaucoma...
Dr. Molly Orban Joins Wilmington Eye
Wilmington Eye Welcomes New Fellowship-Trained Oculoplastic Surgeon
September 15, 2022 09:00 ET | Wilmington Eye
WILMINGTON, N.C., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Today, Wilmington Eye announced the addition of Dr. Molly Orban, a fellowship trained surgeon in ophthalmic plastic, reconstructive, and orbital...
nacuity-pharmaceuticals-inc.jpg
Nacuity Pharmaceuticals and Arctic Therapeutics Enter Licensing Agreement and Strategic Partnership to Develop NPI-001
September 13, 2022 09:00 ET | Nacuity Pharmaceuticals, Inc.
FORT WORTH, Texas and REYKJAVIK, Iceland, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa,...
22157.jpg
Global Cataract Surgery Devices Market to See 3.9% Annual Growth, Bolstered by Rising Geriatric Population
September 08, 2022 08:33 ET | Research and Markets
Dublin, Sept. 08, 2022 (GLOBE NEWSWIRE) -- The "Cataract Surgery Devices Market By Product, By Type, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added...
Global Advanced Ophthalmology Technologies Market
Global Advanced Ophthalmology Technologies Market Report 2022: Technological Advancements in Ophthalmic Devices Presents Avenues for Growth
September 06, 2022 04:58 ET | Research and Markets
Dublin, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The "Global Advanced Ophthalmology Technologies Market (2022-2027) by Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with...